Fluorescent Nucleosides and Oligonucleotides
Fluorescent Nucleosides and Oligonucleotides
批准号:
9795291
负责人:
YITZHAK TOR
金额:
$1.7万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2021-04-30
关键词:
AddressAdenosineAnticodonBehaviorBindingBiochemicalBiologicalBiological AssayBiological ProcessBiologyBiophysicsCategoriesCell NucleusCharacteristicsChemicalsCodon NucleotidesCoenzymesComplementDNADataDeaminationDevelopmentDiagnosticDiseaseEventFamilyFluorescenceGenerationsGoalsHealthHumanInnate Immune ResponseInosineInvestigationKineticsKnowledgeMessenger RNAMetabolismMethodsModificationMonitorNatureNucleic Acid ProbesNucleic AcidsNucleosidesNucleotidesOligonucleotidesOutcomePathway interactionsPeptide SynthesisPlayPredispositionProcessPropertyProtein BiosynthesisProteinsPyrimidineRNARNA FoldingRNA-Binding ProteinsRibosomal FrameshiftingRibosomesRoleScreening procedureSecond Messenger SystemsShapesStructureTherapeutic AgentsTimeTransfer RNATranslationsVirus Replicationabsorptionanalogbasedesigndrug discoveryimprovednovelnovel diagnosticsnucleobasenucleoside analognucleotide analogprogramsprotein expressionpurine metabolismquantumtooltv watching
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The goal of the proposed program is to design and synthesize new emissive nucleoside and nucleotide
analogs and implement them as probes for monitoring nucleoside- and nucleotide-based transformations as
well as nucleic acids function, structure, dynamics and recognition. Advancing effective fluorescence-based
tools for exploring nucleoside, nucleotide and oligonucleotides, as well as their metabolism, regulatory
processes and interactions with potential therapeutic agents will further knowledge and advance new
diagnostic approaches, facilitating drug discovery. Specifically, we will address:
AIM 1. To design, synthesize and incorporate new isomorphic fluorescent nucleoside and
nucleotides. The main design criteria include: (i) High structural similarity to the native nucleobases to
faithfully mimic their size and shape, as well as hybridization and recognition properties, (ii) Red shifted
absorption spectrum to minimize overlap with the absorption of the natural bases, and (iii) Adequate emission
quantum efficiency and visible emission wavelengths. Efficient synthetic and enzymatic pathways will be
devised, providing the nucleosides, nucleotides and oligonucleotide.
AIM 2. To photophysically and biophysically characterize the modified nucleosides and
oligonucleotides. The photophysical characteristics (e.g., absorption and emission maxima, quantum yield
and brightness, excited state lifetime, as well as susceptibility to environmental polarity and static and dynamic
quenching by native nucleosides) will be rigorously evaluated and interpreted. The outcome of these analyses
and the data generated dictate the utility and potential applications of the nucleoside surrogates.
AIM 3. To implement the promising emissive analogs in biophysical, biochemical and discovery
assays. These assays will facilitate: (i) Studying the enzymatic deamination of adenosine to inosine, which
occurs in three key biological contexts: purine metabolism, mRNA editing and tRNA maturation; (ii)
Investigating the enzymatic synthesis of emissive second messengers, such as c-di-NMPs, and their
interactions with riboswitches and proteins (e.g., STING), (iii) Monitoring RNA–protein binding (e.g., k-
turn/7LAe) and translational events, including programmed ribosomal frameshifting, which could be detrimental
to native protein synthesis, but, when programmed (e.g., in viral replication) can maximize protein expression.
Nucleic acids play central roles in cellular events and, as such, have immense impact on the emergence of
diseases and, in turn, on human health. This necessitates the development of new effective tools for studying
their recognition properties and alteration by exogenous agents. The emissive nucleoside analogs designed
and prepared will be implemented in novel real time fluorescence-based assays. These investigations will
further the fundamental understanding of key biological processes related to disease development and will
have long-term impact on improving human health by advancing knowledge and facilitating drug discovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fluorescent nucleosides, nucleotides and oligonucleotides
-
批准号:10083552
-
项目类别:
-
资助金额:$46.9万
-
财政年份:2021
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent nucleosides, nucleotides and oligonucleotides
-
批准号:10557107
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2021
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent nucleosides, nucleotides and oligonucleotides
-
批准号:10331021
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2021
-
负责人:YITZHAK TOR
-
依托单位:
Cellular uptake of glycoside-based transporters
-
批准号:7577371
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2007
-
负责人:YITZHAK TOR
-
依托单位:
Cellular uptake of glycoside-based transporters
-
批准号:7266070
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2007
-
负责人:YITZHAK TOR
-
依托单位:
Cellular uptake of glycoside-based transporters
-
批准号:7769556
-
项目类别:
-
资助金额:$28.21万
-
财政年份:2007
-
负责人:YITZHAK TOR
-
依托单位:
Cellular uptake of glycoside-based transporters
-
批准号:7919905
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2007
-
负责人:YITZHAK TOR
-
依托单位:
Cellular uptake of glycoside-based transporters
-
批准号:7415037
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2007
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:8845949
-
项目类别:
-
资助金额:$5.07万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:9908107
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:6711312
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:7691870
-
项目类别:
-
资助金额:$2.6万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:7469294
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:6838788
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:7001261
-
项目类别:
-
资助金额:$23.64万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:7174791
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:8839777
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:7591191
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:8019535
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
Fluorescent Nucleosides and Oligonucleotides
-
批准号:8370596
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2004
-
负责人:YITZHAK TOR
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: